Surface modification technologies have been successfully used for more than a decade across multiple device applications to reduce risk of thrombosis, bacterial adhesion and biofouling.
In this webinar, Jeannette Ho and Alexandra Piotrowicz, some of the core principal developers of the Endexo®
surface modification technology, share key tips on how medical device companies can enhance device functionality and biocompatibility while minimizing disruption to standard manufacturing processes and accelerating speed to market.
As a participant of this webinar you will learn about:
- Patient risks for thrombus formation, bacterial adhesion and biofouling
- Key polymer and manufacturing process compatibility requirements
- How platforms require structural and chemical versatility to address specific application requirements
- Clinical outcomes from customer studies with devices approved for cardiovascular and urinary applications